#Canada #Toronto #gene therapy #Cell Therapy #Xtalks

Bypassing Bottlenecks: A Deep Dive into Multi-Modality for Next-Gen Cell and Gene Therapy

In an era where cell and gene therapies (CGTs) are drastically reshaping the landscape of healthcare, professionals in the field are constantly tasked with overcoming various challenges. The upcoming webinar, hosted by Xtalks, aims to elucidate how integrated analytical strategies can propel CGT development across diverse modalities. Scheduled for September 30, 2026, this event promises to deliver essential insights into addressing the complexities of these advanced therapies.

Cell and gene therapies offer groundbreaking interventions across various medical domains, including oncology, rare disorders, hematology, and regenerative medicine. However, as these innovative treatments progress through clinical phases, sponsors face mounting difficulties in confirming safety, identity, purity, potency, and maintaining long-term effectiveness—all while navigating the complexities of evolving regulatory standards.

This webinar will feature expert speakers who will delve into a multi-modal analytical strategy designed to accelerate the development of CGTs and mitigate pressing translational bottlenecks. Attendees will gain an understanding of the varying forms of cell therapies, including CAR-T and hematopoietic stem cell therapies, in contrast to gene therapies like AAV-based and RNA therapeutics.

The session will spotlight the synergy between specialized technologies such as flow cytometry, genomics, and bioanalytical testing, revealing how these tools collaboratively offer a comprehensive view of therapeutic products. Participants will learn how these multifaceted approaches can be harnessed to evaluate cellular phenotypes, investigate genetic modifications, and assess therapeutic efficacy—all while generating the integrated datasets necessary for clinical and regulatory success.

Aside from the scientific insights, experts will also discuss the operational hurdles associated with implementing complex characterization strategies across global clinical trials. Participants will be equipped with practical strategies for assay standardization, data integration, and achieving consistent deployment across regions, thereby enhancing scalability and ensuring successful trial outcomes.

Those interested are encouraged to register for this informative webinar, which promises to bridge the critical gap between molecular design and cellular functionality. This approach aims to facilitate more informed decision-making, lower development risks, and successfully transition next-generation CGTs from the discovery phase to market execution.

Experts from Cerba Research, including Kirsty Maclean, the Global Head of Research Development, and Karthikeyan Devaraju, a Senior Scientist in Cell and Gene Therapy, will lead discussions. Join them live on September 30, 2026, at 11 AM EDT (5 PM CEST).

For further details and registration, please visit the Xtalks platform. As a leading entity in the life sciences community, Xtalks continues to empower professionals in the pharmaceutical, biotech, medtech, and healthcare sectors with vital knowledge and insights needed to stay ahead in a rapidly evolving industry.

For more information about Xtalks and to explore opportunities to host your webinar, please visit www.xtalks.com or reach out via the provided contact details.

Together, we can enhance our understanding of the intricate world of cell and gene therapies, ensuring better outcomes for patients in need.